Students, faculty mystified as NSF turns back applications for prestigious fellowship

A seeming uptick in rejections has come with little explanation. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

February 11, 2026 Check out STAT+

Sponsored By

Subscribe to STAT+ today and get 50% off an annual subscription — use code FEB2026 at checkout. Thanks for reading!

Adobe Students, faculty mystified as NSF turns back applications for prestigious fellowship program A wave of NSF GRFP applications returned without review, most in life sciences, is fueling concern that priorities are tilting toward AI and physics. By Jonathan Wosen STAT+ | Prasad overruled FDA staff to reject Moderna's flu vaccine application The rejection of Moderna's flu shot application is the latest example of Vinay Prasad overruling career FDA scientists to place vaccines under harsher scrutiny. By Lizzy Lawrence STAT+ | Hims is in the crosshairs. Is a crackdown coming for compounding? A crackdown on Hims, depending on the focus, could impact a national network of compounding pharmacies and telehealth companies. By Katie Palmer Anna Moneymaker/Getty Images We tested the government's official new AI nutrition tool: Grok Government's new realfood.gov site uses Grok to answer nutrition questions, raising concerns about accuracy, bias, and AI use in health advice. By Sarah Todd WHO director-general calls plans for U.S.-funded vaccine trial 'unethical' A proposed hepatitis B trial where children in Guinea-Bissau would be left unprotected by vaccines for six weeks 'is not ethical,' says WHO chief. By Helen Branswell Lung cancer in 'never-smokers' draws new focus — and questions As more lung cancers appear in nonsmokers, experts question whether U.S. screening guidelines, built around smoking, are leaving high-risk patients behind. By Andrew Joseph Adobe Opinion: My granddaughter has a rare disease. But clinical trials often exclude patients like her Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter are often left out. By Theron Odlaug STAT+ | Trump officials push for skimpier coverage in ACA marketplaces The 2027 ACA marketplace could offer plans with lower premiums but high deductibles — appealing to healthier people but risky for those who need care. By Bob Herman and Tara Bannow For heart health, low-carb or low-fat diet works, as long as it's high quality: study To reduce heart disease risk, it's the quality, not the quantity, of carbs or fats that matter, says new study from the American College of Cardiology. By Elizabeth Cooney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser